Swiss-based confectioner Nestle is reportedly reducing its grip on France beauty product maker L’Oreal, reports say, as L’Oreal plans to buy back some of its shares.
To finance the re-acquisition of the stock, L’Oreal will reportedly divest its 50 percent stake in Swiss dermatology pharmaceutical Galderma; the company is a joint venture between Nestle and L’Oreal. Nestle will pay L’Oreal about $4.2 billion for the sale.
An additional $4.6 billion of the deal will be paid in cash by L’Oreal.
The shake-up in L’Oreal and Nestle’s partnership will also result in a reduction of Nestle representatives on the L’Oreal board, from three to two directors.
Competition authorities will need to clear the planned transactions.
Full Content: FoodBev
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile Faces Class-Action Lawsuit Over Sprint Merger After Appeal Denied
May 16, 2024 by
CPI
Google Faces Backlash Over Introduction of AI-Generated Summaries in Searches
May 16, 2024 by
CPI
CMA Launches Phase 2 Probe into AlphaTheta’s Acquisition of Serato
May 16, 2024 by
CPI
NFL Executive Escapes Testifying in High-Stakes Trial Over Televised Games
May 16, 2024 by
CPI
EU Consumers Lodge Complaint Against Chinese Retailer Temu Over Content Rules Breach
May 16, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI